サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1507220

そう痒症治療薬市場、シェア、規模、動向、産業分析レポート：疾患タイプ別、製品別、地域別、セグメント別予測、2024年～2032年

Pruritus Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Allergic Contact Dermatitis, Atopic Dermatitis, Urticaria, Others); By Product; By Region; Segment Forecast, 2024 - 2032

出版日
ページ情報
英文 120 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
そう痒症治療薬市場、シェア、規模、動向、産業分析レポート：疾患タイプ別、製品別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年06月01日
発行: Polaris Market Research
ページ情報: 英文 120 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、そう痒症治療薬の世界市場規模は2032年までに132億米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

さまざまな皮膚疾患や全身疾患に関連した慢性的なかゆみの有病率の増加により、そう痒症治療薬市場は大きな成長を遂げています。そう痒症が患者のQOLに大きな影響を与えるという認識が広まり、効果的な治療オプションに対する需要が高まっています。医薬品の進歩、特に新しい生物学的製剤や標的治療の創出は、そう痒症に利用できる治療法の幅を広げ、患者の予後改善につながります。さらに、持続的なかゆみを引き起こす疾患に罹患しやすい世界人口の高齢化が、市場の成長をさらに促進しています。

市場の主な動向としては、そう痒症の根底にある分子メカニズムを特異的に標的とする生物学的薬剤や免疫調節剤の開発と使用が挙げられます。また、局所治療の有効性と密着性を高めるために、先進的なドラッグデリバリーシステムを取り入れる動きも活発化しています。

皮膚疾患の発生率の増加は、そう痒症治療薬市場の主要な促進要因です。これらの疾患は慢性的なかゆみとして現れることが多く、患者のQOLに大きな影響を与えています。都市化、汚染、ライフスタイルの変化などの要因が、湿疹、乾癬、アトピー性皮膚炎などの皮膚疾患の世界の有病率の上昇に寄与しており、その結果、皮膚バリアが損なわれ、免疫系が変化しています。さらに、大手製薬企業や新興バイオテクノロジー企業間の激しい競合が、そう痒症治療薬市場の競合情勢を特徴づけています。業界をリードするこれらの企業は、先進的な生物製剤、免疫調節薬、標的療法を活用して、そう痒症の根本原因に対処する革新的な治療法を開発しています。

そう痒症治療薬市場レポートハイライト

2023年のそう痒症治療薬の世界市場は、その高い有病率と慢性化により、主にアトピー性皮膚炎市場が牽引しています。アトピー性皮膚炎の主な症状は、激しい持続的なかゆみであることが多いです。

2023年のそう痒症治療薬市場では、副腎皮質ステロイドの売上高シェアが最も高かったです。これは主に、皮膚そう痒症を引き起こすさまざまな炎症性皮膚疾患の治療において、副腎皮質ステロイドが幅広く利用され、有効性が確立されているためです。

2023年、北米はアトピー性皮膚炎、乾癬、湿疹などの皮膚疾患の有病率が高いことから、世界市場の主要地域としての地位を確立しました。これらの疾患は、同地域におけるそう痒症治療薬の需要を大幅に押し上げています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のそう痒症治療薬市場の洞察

  • 業界スナップショット
  • そう痒症治療薬市場力学
    • 促進要因と機会
      • 皮膚疾患の罹患率の増加
      • バイオテクノロジーと薬理学の進歩
    • 抑制要因と課題
      • 副作用と安全性の懸念
  • PESTLE分析
  • そう痒症治療薬業界の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のそう痒症治療薬市場：疾患タイプ別

  • 主な調査結果
  • イントロダクション
  • アレルギー性接触皮膚炎
  • アトピー性皮膚炎
  • 蕁麻疹
  • その他

第6章 世界のそう痒症治療薬市場：製品別

  • 主な調査結果
  • イントロダクション
  • 抗ヒスタミン薬
  • カルシニューリン阻害剤
  • コルチコステロイド
  • 抗刺激剤
  • 免疫抑制剤
  • 局所麻酔薬
  • その他

第7章 世界のそう痒症治療薬市場：地域別

  • 主な調査結果
  • イントロダクション
    • そう痒症治療薬市場評価：地域別、2019-2032年
  • 北米
    • 北米：製品別、2019-2032年
    • 北米：疾患タイプ別、2019年～2032年
    • 米国
    • カナダ
  • 欧州
    • 欧州：製品別、2019-2032年
    • 欧州：疾患タイプ別、2019-2032年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
  • アジア太平洋地域
    • アジア太平洋地域：製品別、2019年～2032年
    • アジア太平洋地域：疾患タイプ別、2019年～2032年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
  • 中東・アフリカ
    • 中東・アフリカ：製品別、2019年～2032年
    • 中東・アフリカ：疾患タイプ別、2019-2032年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：製品別、2019-2032年
    • ラテンアメリカ：疾患タイプ別、2019-2032年
    • メキシコ
    • ブラジル
    • アルゼンチン

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • AbbVie Inc
  • Amgen Inc
  • Astellas Pharma Inc
  • Bristol Myers Squibb
  • Cara Therapeutics
  • GSK plc
  • Novartis AG
  • Pfizer Inc
  • Sanofi
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc
図表

List of Tables

  • Table 1 Global Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 3 Pruritus Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 4 North America: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 5 North America: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 6 U.S.: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 7 U.S.: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 8 Canada: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 9 Canada: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 10 Europe: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 11 Europe: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 12 UK: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 13 UK: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 14 France: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 15 France: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 16 Germany: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 17 Germany: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 18 Italy: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 19 Italy: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 20 Spain: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 21 Spain: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 22 Netherlands: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 23 Netherlands: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 24 Russia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 25 Russia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 26 Asia Pacific: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Asia Pacific: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 28 China: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 29 China: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 30 India: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 31 India: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 32 Malaysia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Malaysia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 34 Japan: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 35 Japan: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 36 Indonesia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 37 Indonesia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 38 South Korea: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 39 South Korea: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 40 Middle East & Africa: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 41 Middle East & Africa: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 42 Saudi Arabia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 43 Saudi Arabia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 44 UAE: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 45 UAE: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 46 Israel: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 47 Israel: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 48 South Africa: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 49 South Africa: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 50 Latin America: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Latin America: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 52 Mexico: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 53 Mexico: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 54 Brazil: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 55 Brazil: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 56 Argentina: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • Table 57 Argentina: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Global Pruritus Therapeutics Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Product
  • Figure 7 Global Pruritus Therapeutics Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Disease Type
  • Figure 9 Global Pruritus Therapeutics Market, by Disease Type, 2022 & 2032 (USD Billion)
  • Figure 10 Pruritus Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Pruritus Therapeutics Market
目次
Product Code: PM1301

The global Pruritus Therapeutics market size is expected to reach USD 13.2 Billion by 2032, according to a new study by Polaris Market Research. The report "Pruritus Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Allergic Contact Dermatitis, Atopic Dermatitis, Urticaria, Others); By Product; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market for treating pruritus is seeing significant growth as a result of the increasing prevalence of chronic itching linked to various skin and systemic conditions. The growing awareness of pruritus's substantial impact on patient's quality of life is boosting the demand for effective treatment options. Advances in pharmaceuticals, particularly the creation of new biologics and targeted therapies, are broadening the range of treatments available for pruritus, leading to better patient outcomes. Additionally, the aging global population, which is more prone to conditions causing persistent itching, is further propelling market growth.

Key trends in the market include the development and use of biological drugs and immunomodulators that specifically target the molecular mechanisms underlying pruritus. The incorporation of advanced drug delivery systems to improve the effectiveness and adherence of topical treatments is also gaining momentum.

The rising incidence of dermatological disorders is a key driver for the pruritus therapeutics market. These conditions often manifest as chronic itching, significantly impacting patients' quality of life. Factors such as urbanization, pollution, and lifestyle changes contribute to the increasing global prevalence of skin diseases like eczema, psoriasis, and atopic dermatitis, resulting in compromised skin barriers and immune system changes. Furthermore, intense competition among major pharmaceutical companies and emerging biotech firms characterize the competitive landscape of the pruritus therapeutics market. These industry leaders are leveraging advanced biologics, immunomodulators, and targeted therapies to develop innovative treatments that address the root causes of pruritus.

Pruritus Therapeutics Market Report Highlights

The global market for pruritus therapeutics in 2023 was primarily driven by the atopic dermatitis segment, owing to the condition's high prevalence and chronicity. This condition is often characterized by severe and persistent itching as a primary symptom.

The corticosteroids segment had the highest revenue share in the pruritus therapeutics market in 2023. This was primarily due to their extensive utilization and established effectiveness in treating various inflammatory skin conditions that result in pruritus.

In 2023, North America established itself as the leading region in the global market due to its high prevalence of dermatological conditions like atopic dermatitis, psoriasis, and eczema. These conditions have significantly boosted the demand for pruritus treatments in the region.

The global key market players include AbbVie Inc., Amgen Inc., Astellas Pharma Inc., Bristol Myers Squibb, Cara Therapeutics, GSK plc, Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Viatris Inc., among others.

Polaris Market Research has segmented the pruritus therapeutics market report based on disease type, product, and region:

Pruritus Therapeutics, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Allergic Contact Dermatitis
  • Atopic Dermatitis
  • Urticaria
  • Othersc

Pruritus Therapeutics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Antihistamines
  • Calcineurin Inhibitors
  • Corticosteroids
  • Counterirritants
  • Immunosuppressant
  • Local Anesthetics
  • Others

Pruritus Therapeutics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Pruritus Therapeutics Market Insights

  • 4.1. Pruritus Therapeutics Market - Industry Snapshot
  • 4.2. Pruritus Therapeutics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Dermatological Conditions
      • 4.2.1.2. Advances in Biotechnology and Pharmacology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Adverse Effects and Safety Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Pruritus Therapeutics Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Pruritus Therapeutics Market, by Disease Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Pruritus Therapeutics, by Disease Type, 2019-2032 (USD Billion)
  • 5.3. Allergic Contact Dermatitis
    • 5.3.1. Global Pruritus Therapeutics Market, by Allergic Contact Dermatitis, by Region, 2019-2032 (USD Billion)
  • 5.4. Atopic Dermatitis
    • 5.4.1. Global Pruritus Therapeutics Market, by Atopic Dermatitis, by Region, 2019-2032 (USD Billion)
  • 5.5. Urticaria
    • 5.5.1. Global Pruritus Therapeutics Market, by Urticaria, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Pruritus Therapeutics Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Pruritus Therapeutics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Antihistamines
    • 6.3.1. Global Pruritus Therapeutics Market, by Antihistamines, by Region, 2019-2032 (USD Billion)
  • 6.4. Calcineurin Inhibitors
    • 6.4.1. Global Pruritus Therapeutics Market, by Calcineurin Inhibitors, by Region, 2019-2032 (USD Billion)
  • 6.5. Corticosteroids
    • 6.5.1. Global Pruritus Therapeutics Market, by Corticosteroids, by Region, 2019-2032 (USD Billion)
  • 6.6. Counterirritants
    • 6.6.1. Global Pruritus Therapeutics Market, by Counterirritants, by Region, 2019-2032 (USD Billion)
  • 6.7. Immunosuppressant
    • 6.7.1. Global Pruritus Therapeutics Market, by Immunosuppressant, by Region, 2019-2032 (USD Billion)
  • 6.8. Local Anesthetics
    • 6.8.1. Global Pruritus Therapeutics Market, by Local Anesthetics, by Region, 2019-2032 (USD Billion)
  • 6.9. Others
    • 6.9.1. Global Pruritus Therapeutics Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Pruritus Therapeutics Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Pruritus Therapeutics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 7.3. Pruritus Therapeutics Market - North America
    • 7.3.1. North America: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.3.2. North America: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.3.3. Pruritus Therapeutics Market - U.S.
      • 7.3.3.1. U.S.: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.3.3.2. U.S.: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.3.4. Pruritus Therapeutics Market - Canada
      • 7.3.4.1. Canada: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.3.4.2. Canada: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.4. Pruritus Therapeutics Market - Europe
    • 7.4.1. Europe: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.4.2. Europe: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.3. Pruritus Therapeutics Market - UK
      • 7.4.3.1. UK: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.3.2. UK: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.4. Pruritus Therapeutics Market - France
      • 7.4.4.1. France: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.4.2. France: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.5. Pruritus Therapeutics Market - Germany
      • 7.4.5.1. Germany: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.5.2. Germany: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.6. Pruritus Therapeutics Market - Italy
      • 7.4.6.1. Italy: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.6.2. Italy: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.7. Pruritus Therapeutics Market - Spain
      • 7.4.7.1. Spain: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.7.2. Spain: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.8. Pruritus Therapeutics Market - Netherlands
      • 7.4.8.1. Netherlands: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.8.2. Netherlands: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.4.9. Pruritus Therapeutics Market - Russia
      • 7.4.9.1. Russia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.4.9.2. Russia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.5. Pruritus Therapeutics Market - Asia Pacific
    • 7.5.1. Asia Pacific: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.5.2. Asia Pacific: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.3. Pruritus Therapeutics Market - China
      • 7.5.3.1. China: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.3.2. China: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.4. Pruritus Therapeutics Market - India
      • 7.5.4.1. India: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.4.2. India: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.5. Pruritus Therapeutics Market - Malaysia
      • 7.5.5.1. Malaysia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.5.2. Malaysia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.6. Pruritus Therapeutics Market - Japan
      • 7.5.6.1. Japan: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.6.2. Japan: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.7. Pruritus Therapeutics Market - Indonesia
      • 7.5.7.1. Indonesia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.7.2. Indonesia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.5.8. Pruritus Therapeutics Market - South Korea
      • 7.5.8.1. South Korea: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.5.8.2. South Korea: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.6. Pruritus Therapeutics Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.6.2. Middle East & Africa: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.3. Pruritus Therapeutics Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.4. Pruritus Therapeutics Market - UAE
      • 7.6.4.1. UAE: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.4.2. UAE: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.5. Pruritus Therapeutics Market - Israel
      • 7.6.5.1. Israel: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.5.2. Israel: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.6.6. Pruritus Therapeutics Market - South Africa
      • 7.6.6.1. South Africa: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.6.6.2. South Africa: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.7. Pruritus Therapeutics Market - Latin America
    • 7.7.1. Latin America: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
    • 7.7.2. Latin America: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.7.3. Pruritus Therapeutics Market - Mexico
      • 7.7.3.1. Mexico: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.7.3.2. Mexico: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.7.4. Pruritus Therapeutics Market - Brazil
      • 7.7.4.1. Brazil: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.7.4.2. Brazil: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)
    • 7.7.5. Pruritus Therapeutics Market - Argentina
      • 7.7.5.1. Argentina: Pruritus Therapeutics Market, by Product, 2019-2032 (USD Billion)
      • 7.7.5.2. Argentina: Pruritus Therapeutics Market, by Disease Type, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. AbbVie Inc
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Amgen Inc
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Astellas Pharma Inc
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Bristol Myers Squibb
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Cara Therapeutics
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. GSK plc
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Novartis AG
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Pfizer Inc
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Sanofi
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Teva Pharmaceutical Industries Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Viatris Inc
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development